GLPBio

Apoptosis

Read More about this category

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

 

References:

1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.

2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.

3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.

4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.

5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Research Areas

Products Related to Apoptosis(3394)

  • GC68385 structure
    GC68385TNF-α-IN-6
    CAS: 2699704-20-4
    Purity: >98.00%
  • GC68388 structure
    GC68388XIAP degrader-1
    CAS: 2803617-91-4
    Purity: >98.00%
  • GC68404 structure
    GC68404Human PD-L1 inhibitor IV
    CAS: 2135542-83-3
    Purity: >98.00%
  • GC68452 structure
    GC684522,4,6-Triiodophenol
    CAS: 609-23-4
    Purity: >98.00%
  • GC68470 structure
    GC68470SPD304 dihydrochloride
    CAS: 1049741-03-8
    Purity: >99.00%

    SPD304 dihydrochloride은 종양괴사인자 α(TNF-α)의 선택적 억제제로 IC50 값이 22μM이다.

  • GC68537 structure
    GC685373-IN-PP1
    CAS: 2227110-54-3
    Purity: >98.00%

    3-IN-PP1은 단백질 키나제 D (PKD) 억제제입니다. 3-IN-PP1은 PKD1, PKD2 및 PKD3에 대해 유효한 광범위한 PKD 억제 활성을 가지며, 각각의 IC50 값은 108, 94 및 108 nM입니다. 또한, 3-IN-PP1은 폭넓게 항암제이며 다양한 종류의 암세포 성장을 억제하는 작용이 있습니다. 따라서, 3-IN-PP1은 암 연구에 사용될 수 있습니다.

  • GC68562 structure
    GC685625-Aminolevulinic acid-13C-1 hydrochloride
    CAS: 129720-94-1
    Purity: >98.00%

    5-Aminolevulinic acid-13C-1 (5-ALA-13C-1) hydrochloride는 13C 표지된 5-Aminolevulinic acid hydrochloride입니다. 5-Aminolevulinic acid hydrochloride (5-ALA hydrochloride)는 체내 혈색소 생물합성의 중간체이며, 테트라피롤의 전구체입니다.

  • GC68600 structure
    GC68600Ac-DEVD-CMK TFA
    Purity: >98.00%

    Ac-DEVD-CMK (Caspase-3 Inhibitor III) TFA는 선택적이고 불가역적인 카스패이스-3 억제제입니다. Ac-DEVD-CMK TFA는 고수준의 포도당 또는 3,20-dibenzoate (IDB; 5) 유도에 의한 세포사멸을 유의하게 억제합니다. Ac-DEVD-CMK TFA는 다양한 실험 방법에서 세포사멸을 억제하기 위해 사용될 수 있습니다.

  • GC68621 structure
    GC68621Ac-WEHD-AFC TFA
    Purity: >98.00%

    Ac-WEHD-AFC TFA는 형광 caspase-1 기질입니다. Ac-WEHD-AFC TFA는 종양 및 염증 연구에 사용되며 caspase-1 형광 활성을 감지할 수 있습니다.

  • GC68632 structure
    GC68632AK-778-XXMU
    CAS: 1227045-76-2
    Purity: >99.50%

    AK-778-XXMU는 DNA 결합 2(ID2) 억제제의 효과적인 억제제로, KD는 129 nM입니다. AK-778-XXMU는 신경교종 세포주의 이동 및 침습을 억제하며, 세포 자살(apoptosis)을 유도하고 더 중요한 것은 종양 성장을 감소시킬 수 있습니다.

  • GC68700 structure
    GC68700ASR-488
    CAS: 2690312-65-1
    Purity: >99.00%

    ASR-488는 활성화할 수 있는 mRNA 결합 단백질 CPEB1을 유도하여 세포의 아포토시스를 유도하고 방광암의 성장을 억제합니다.

  • GC68729 structure
    GC68729Bax activator-1
    CAS: 1638526-94-9
    Purity: >98.00%

    Bax 활성화제-1 (화합물 106)는 Bax를 활성화시키는 물질로, Bax 의존적 종양 세포의 세포사멸을 유도합니다.

  • GC68744 structure
    GC68744BC-?1258
    CAS: 1507370-40-2
    Purity: >98.00%

    BC-1258는 F-box/LRR 반복 단백질 2 (FBXL2) 활성화제로, FBXL2 수준을 안정화하고 상승시킬 수 있습니다. BC-1258은 종양 세포의 세포사멸을 유도하며, 마우스의 종양 형성을 유의하게 억제합니다.

  • GC68757 structure
    GC68757BH3 hydrochloride
    Purity: >98.00%

    BH3 염산염은 혈-뇌 장벽을 통과할 수 있는 다형성이며, 직접적으로 프로아포토닉 Bax/Bak를 활성화하거나 항아폐 성 블록-2 단백질 (Bcl-2, Bcl-XL, Bcl-w, mcl1 및 A-1)을 중화하여 세포의 자살을 유도합니다. 이는 BH3 구조 도메인에 결합함으로써 이루어집니다.

  • GC68765 structure
    GC68765Bim-IN-1
    CAS: 2909483-36-7
    Purity: >99.00%

    Bim-IN-1은 Bim 발현 억제제로 효과적이며, Bim-IN-1은 Bim의 발현 수준을 낮출 수 있으며 단백질 키나아제 A에 대한 억제 작용이 거의 없으며 동시에 낮은 독성도 가지고 있습니다.

  • GC68769 structure
    GC68769Biotin-COG1410 TFA
    Purity: >99.00%

    Biotin-COG1410 TFA는 생물소화된 COG1410입니다. COG1410은 지질결합단백질 E의 유래 펩타이드 및 세포사멸 억제제입니다. COG1410은 마우스 뇌손상(TBI) 모델에서 신경보호 및 항염작용을 발휘합니다. COG1410은 신경계 질환 연구에 사용될 수 있습니다.

  • GC68774 structure
    GC68774Bleomycin A5
    CAS: 11116-32-8
    Purity: >98.00%

    블레오마이신 A5 (핑양마이신)은 당펩타이드류 항생제로서 경구 흡수 활성을 가지고 있습니다. 블레오마이신 A5는 항암제, 세포 사멸 유도제 및 세균 대사 생성물의 역할을 합니다.

  • GC68787 structure
    GC68787Boc-Asp(OMe)-fluoromethyl ketone
    CAS: 187389-53-3
    Purity: >98.00%

    Boc-Asp(OME)-Fluoromethyl Keton은 광범위한 caspase 억제제로, Fas 매개의 흡수 작용과 산화 분해 억제를 억제할 수 있지만 IL-8의 유인 활성에는 영향을 미치지 않습니다.

  • GC68815 structure
    GC68815Budigalimab
    CAS: 2098225-93-3
    Purity: >98.00%

    Budigalimab (ABBV 181; PR 1648817)은 PD-1 수용체를 대상으로하는 인간 유래 IgG1 단일 클론 항체입니다. Budigalimab은 Fc 돌연변이를 가지고 있어 Fc 수용체 상호 작용 및 효과 인자 억제 작용을 감소시켰습니다.

  • GC68826 structure
    GC68826Cantrixil
    CAS: 2135511-22-5
    Purity: >98.00%

    Cantrixil (TRX-E-002-1) is the active enantiomer of TRX-E-002 and a second-generation superbenzopyran compound. Cantrixil increases phosphorylation levels of c-Jun, leading to caspase-mediated apoptosis in ovarian cancer cells. Cantrixil has effective anti-cancer activity against a broad range of cancer phenotypes.

  • GC68857 structure
    GC68857Cetrelimab
    CAS: 2050478-92-5
    Purity: >98.00%

    Cetrelimab (JNJ 63723283; JNJ 3283)은 PD-1을 표적으로 하는 인간화된 IgG4 κ 단일클론 항체입니다. Cetrelimab은 HEK293 세포에서 PD-1에 결합하는 Kd가 1.72 nM입니다. 이로 인해, Cetrelimab은 PD-1과 PD-L1 및 PD-L2의 상호 작용을 차단합니다(IC50 각각 111.7 ng/mL 및 138.6 ng/mL). 또한, Cetrelimab은 주변 T 세포를 자극하여 IFN-γ, IL-2, TNF-α와 같은 세포 염증성 사이트카인 수준을 증가시키고 체내 종양 성장을 억제합니다.

  • GC68873 structure
    GC68873Citric acid trisodium
    CAS: 68-04-2
    Purity: >98.00%

    시트르산 트리소듐은 천연 방부제 및 식품 산미증강제입니다. 시트르산 트리소듐은 세포의 아포토시스 유도와 G2/M 단계 및 S 단계에서 세포 주기 정지를 유발합니다. 시트르산 트리소듐은 항산화 효소 활성을 감소시켜 간 손상을 일으킵니다. 시트르산 트리소듐은 마우스에게 신독성을 미칩니다.

  • GC68882 structure
    GC68882Cleomiscosin A
    CAS: 76948-72-6
    Purity: >98.00%

    Cleomiscosin A는 Macaranga adenantha에서 생산되는 쿠마린 유래의 목질 소재입니다. Cleomiscosin A는 마우스 복강 거대 세포에서 TNF-알파 분비에 대한 활성을 가지고 있습니다.

  • GC68903 structure
    GC68903cRIPGBM chloride
    CAS: 2361988-77-2
    Purity: >99.00%

    cRIPGBM chloride는 경구 투여 가능한 세포 사멸 유도 파생물로, cRIPGBM은 다형성 뇌교연조직종 (GBM) 암 줄기세포(CSC)에서 생성됩니다. cRIPGBM chloride는 수용체 상호작용 단백질 키나아제 2(RIPK2)를 타겟으로 하여 반카다버린 caspase 1 의존적인 세포사멸을 유도합니다. cRIPGBM chloride는 RIPK2/TAK1(생존 프렉시마)의 형성을 억제하고 RIPK2/caspase 1(세포사멸 프렉시마)의 형성을 증가시킵니다. cRIPGBM chloride는 동물 모델에서 강력한 체내 항암 활성을 나타냅니다.